105 related articles for article (PubMed ID: 19080849)
1. [Impact of hemoglobin level on lung cancer survival].
García Prim JM; González Barcala FJ; Moldes Rodríguez M; Alvarez Dobañob JM; Hervada Vidal X; Pose Reino A; Valdés Cuadrado L
Med Clin (Barc); 2008 Nov; 131(16):601-4. PubMed ID: 19080849
[TBL] [Abstract][Full Text] [Related]
2. Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.
Aoe K; Hiraki A; Maeda T; Katayama H; Fujiwara K; Tabata M; Kiura K; Ueoka H; Tanimoto M
Intern Med; 2005 Aug; 44(8):800-4. PubMed ID: 16157976
[TBL] [Abstract][Full Text] [Related]
3. The importance of pre-treatment haemoglobin level in inoperable non-small cell lung carcinoma treated with radical radiotherapy.
Langendijk H; de Jong J; Wanders R; Lambin P; Slotman B
Radiother Oncol; 2003 Jun; 67(3):321-5. PubMed ID: 12865181
[TBL] [Abstract][Full Text] [Related]
4. Leptomeningeal carcinomatosis in non-small-cell lung cancer patients: impact on survival and correlated prognostic factors.
Lee SJ; Lee JI; Nam DH; Ahn YC; Han JH; Sun JM; Ahn JS; Park K; Ahn MJ
J Thorac Oncol; 2013 Feb; 8(2):185-91. PubMed ID: 23328548
[TBL] [Abstract][Full Text] [Related]
5. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
Rades D; Setter C; Schild SE; Dunst J
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1134-42. PubMed ID: 18258387
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
[TBL] [Abstract][Full Text] [Related]
7. Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: the JBR.10 trial experience.
Gauthier I; Ding K; Winton T; Shepherd FA; Livingston R; Johnson DH; Rigas JR; Whitehead M; Graham B; Seymour L
Lung Cancer; 2007 Mar; 55(3):357-63. PubMed ID: 17141357
[TBL] [Abstract][Full Text] [Related]
8. Impact of preoperative hemoglobin level on survival of non-small cell lung cancer patients.
Tomita M; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2008; 28(3B):1947-50. PubMed ID: 18630486
[TBL] [Abstract][Full Text] [Related]
9. Concurrent low-dose cisplatin and thoracic radiotherapy in patients with inoperable stage III non-small cell lung cancer: a phase II trial with special reference to the hemoglobin level as prognostic parameter.
Pradier O; Lederer K; Hille A; Weiss E; Christiansen H; Schmidberger H; Hess CF
J Cancer Res Clin Oncol; 2005 Apr; 131(4):261-9. PubMed ID: 15616830
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between anemia and clinical features and prognosis of advanced lung cancer patients].
Wang L; Shao ZH
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):512-516. PubMed ID: 30060359
[No Abstract] [Full Text] [Related]
11. A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.
Bozkaya Y; Kurt B; Gürler F
Int J Clin Oncol; 2019 Jul; 24(7):798-806. PubMed ID: 30783810
[TBL] [Abstract][Full Text] [Related]
12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer.
Diez M; Torres A; Pollán M; Gomez A; Ortega D; Maestro ML; Granell J; Balibrea JL
Cancer; 1994 Mar; 73(5):1368-76. PubMed ID: 8111703
[TBL] [Abstract][Full Text] [Related]
14. Chemoradiotherapy-induced hemoglobin nadir values and survival in patients with stage III non-small cell lung cancer.
Topkan E; Selek U; Ozdemir Y; Yildirim BA; Guler OC; Mertsoylu H; Hahn SM
Lung Cancer; 2018 Jul; 121():30-36. PubMed ID: 29858023
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of decreased pretreatment haemoglobin level on the survival of patients with lung cancer: a systematic review and meta-analysis.
Huang Y; Wei S; Jiang N; Zhang L; Wang S; Cao X; Zhao Y; Wang P
BMC Cancer; 2018 Dec; 18(1):1235. PubMed ID: 30526532
[TBL] [Abstract][Full Text] [Related]
16. Anemia in patients with advanced or metastatic non-small cell lung cancer.
Abuzallouf S; Wright J; El Hattab O
Gulf J Oncolog; 2007 Jan; 1(1):17-21. PubMed ID: 20084709
[TBL] [Abstract][Full Text] [Related]
17. Role of preoperative blood markers as prognostic factors for lung cancer surgery.
Hamid UI; Al-Saudi R; Paul I; Graham A
Asian Cardiovasc Thorac Ann; 2019 May; 27(4):288-293. PubMed ID: 30832488
[TBL] [Abstract][Full Text] [Related]
18. Enhanced eryptosis contributes to anemia in lung cancer patients.
Bissinger R; Schumacher C; Qadri SM; Honisch S; Malik A; Götz F; Kopp HG; Lang F
Oncotarget; 2016 Mar; 7(12):14002-14. PubMed ID: 26872376
[TBL] [Abstract][Full Text] [Related]
19. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
20. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
